The present invention relates to wound dressings and more particularly, though not exclusively, to wound dressings used in topical negative pressure therapy (TNP) and to devices for sealing such dressings to conduits, tubes and the like passing in and/or out of a dressing covering the wound site.
Our co-pending International patent applications, WO 2004/037334, WO 2005/046760 and WO 2005/105180, describe inter alia and variously apparatus and methods for the treatment of wounds by aspiration, irrigation and cleansing, and are hereby incorporated by reference in their entireties. The apparatus and methods all involve in their most general aspects the covering of the wound site with a dressing which is sealed to the skin surrounding the wound by a flexible membrane type material through which or sealed thereto are conduits or tubes carrying fluids to the wound site and/or carrying wound exudates/fluids away from the wound site. The fluids may be liquids such as wound exudates and/or irrigation or cleansing fluids such as saline, for example, but may also be gases such as air, for example, used to aerate the wound site and to assist the liquid fluids away from the wound site by aspiration means.
The above referenced International patent applications all describe relatively complex systems for treating wounds by therapy usually involving a plurality of conduits needing to be sealed in respect of the dressing/wound site in order to preventingress of ambient atmosphere into the wound site and to enable the apparatus to work effectively and efficiently without significant leakage.
Other less complex forms of apparatus are available which only apply TNP therapy to a wound and effectively there may be generally only one conduit or tube passing into the wound site.
Generally, conduits or tubes passing into the wound site are sealed to a flexible wound covering membrane or film by “pinching” the flexible covering around the conduit or tube so as to both stick the membrane material to the conduit or tube and also to itself to form a seal with the tube. Generally, the types of flexible membrane material used for wound coverings are provided with an adhesive layer such as a pressure sensitive adhesive, for example, in order for the material to adhere to the skin surrounding a wound. This method of sealing does not always work well and the seal around the conduit or tube degrades over time due to patient movements and adhesive-moisture interaction.
US2007/0032778, EP 1088569B show other types of connection devices and methods and are hereby incorporated by reference in their entireties. However, these mean that the patient is left with a moulding about in the centre of a wound that may cause pain and trauma if the patient lies upon it. Furthermore, such devices do not serve well for complex dressings such as those employing inflatable bladders, for example, or for small awkwardly sited wounds such as diabetic foot ulcers, for example.
Such methods of forming a seal with a conduit or tube are not always ideal. For example, sometimes it is desirable to be able to adjust the position of or extent of conduit or tube insertion into the wound site after the dressing has been adhered to the conduit or tube. This usually results in rupture or tearing of the flexible membrane which then needs to be repaired with additional material or the dressing replaced in its entirety.
The present invention has been devised to overcome failings of prior art methods of sealing conduits or tubes to dressings.
According to a first aspect of the present invention there is provided a grommet for locating and sealably receiving at least one flexible conduit having an end to be located within a dressing at a wound site, the grommet comprising at least one aperture therethrough for sealably receiving a conduit and a first face for contacting a patient's skin adjacent a wound.
The grommet may have an adhesive coating on the first face. The adhesive coating may be protected prior to use of the grommet by a protector layer comprising a known paper material, for example, impregnated or coated with a suitable material of low adhesion characteristic to the adhesive layer on the grommet such as silicone, for example.
The grommet may also be provided with a flange portion extending around at least a part of a body portion thereof so as to co-operate with a dressing to be described hereinbelow. The flange portion may extend completely around a body portion of the grommet.
The grommet according to the first aspect of the present invention may have a plurality of apertures therethrough to receive a plurality of conduits.
The first face of the grommet may be coated with an adhesive as discussed hereinbelow in more detail. However, the first face may be adhered to a patient's skin by means of a separate piece of drape backing material folded in two, for example, so that it has adhesive coated faces facing upwardly and downwardly; one face adhering to the first face of the grommet and the other face adhering to the patient's skin so as to adhere the grommet thereto.
According to a second aspect of the present invention, there is provided a dressing for use with a grommet member used to locate and retain conduits and/or tubes used in therapy of a wound, the dressing comprising a backing layer having an adhesive coating thereon for adhering the dressing to a patient; the backing layer having a cut-out therein for receiving a grommet member.
According to a third aspect of the present invention there is provided a combination of a dressing for use with a grommet member used to locate and retain conduits and/or tubes used in therapy of a wound, the dressing comprising a backing layer having an adhesive coating thereon for adhering the dressing to a patient; the backing layer having a cut-out therein for receiving a grommet member and, a grommet member having at least one aperture therethrough for receiving a conduit.
In the combination according to the third aspect of the present invention the grommet member preferably further comprises a flange portion extending around at least a part of a body portion of the grommet for attaching the grommet member to said adhesive coated backing layer.
The backing layer may be a thin flexible film material and comprise any suitable material known to those skilled in the art and may comprise one of the materials described in EP-A-0 751 757 which is hereby incorporated by reference in its entirety.
For example, the backing layer may comprise polyurethanes such as polyester or polyether polyurethanes and commercially available materials such as OPSITE (trade mark) or TEGADERM (trade mark). Desirably the backing material is initially supplied, as is well known in the art, having a protector layer adhered to the adhesive coated face and, preferably a support (sometimes referred to as a “carrier”) layer on the reverse face to the adhesive coated face. The protector layer may again be any material known to those skilled in the art and silicone coated release paper is one example. The support layer may also be any suitable material known to those skilled in the art and suitable examples of which may include paper, foil or polymeric films. Preferably, the support layer is more strongly adhered to the backing layer than the protector layer so that the when the protector layer is peeled away the support layer remains to prevent any undesirable wrinkling of the backing layer, facilitate handling thereof and to maintain the generally 2-dimensional shape of the backing layer. Once the dressing has been adhered to the patient, the support layer may then be peeled away.
Suitable adhesives may be pressure sensitive adhesives which are well known to those skilled in the dressings art.
In a first embodiment of the dressing according to the present invention, the cut-out in the backing layer may be in the form of a bite out of one edge of the backing layer, effectively rendering the shape of the backing layer as a “horseshoe” form. It is preferred that the direction of the conduits in the grommet member may be aligned with and pass over the cut-out in the dressing edge.
In a second embodiment of the dressing according to the present invention, the cut-out may be an aperture in the backing layer leaving the backing layer as a ring form, for example, a square ring.
The apertured shape of backing layer is preferred since the grommet member is then supported entirely around its periphery and the adhesive layer on the backing layer is available for adhering the dressing to the patient around the entire periphery of the backing layer and grommet member thus enhancing the seal to the patient's skin of the dressing.
However, the horseshoe shaped backing layer is acceptable in that the grommet member is sealed against ambient atmosphere on the wound side. An advantage of this shape of dressing is that the patient's skin may be allowed to breath or vent sweat to the periphery from underneath the grommet member via the open edge. The grommet member is preferably formed from a soft polymeric plastics material. In some embodiments, the grommet member is also made from a stretchable material. Typically, the grommet member material may have a shore hardness in the range 55 A-70 A and easily conforms to a patient's contours, however, this hardness is not limiting and hardnesses outside this range may be perfectly suitable for use in the grommet member according to the present invention. Suitable materials for the grommet member include TPE, polyurethane, ethylvinylacetate, silicone, polyvinylchloride, for example. Furthermore, the grommet member is generally covered and additionally held down to the patients skin by an overlying adhesive drape material membrane which covers the whole of the wound site. Alternatively, as stated above, the grommet member may be provided with an adhesive coating on the face which contacts the patient's skin, the adhesive coated face being initially provided with a protector layer as with the backing layer. Thus the dressing and grommet member are completely sealed to the patient.
When the dressing is being attached to a patient's skin adjacent a wound, it is desirable that the grommet already has the required conduit or conduits installed to prevent any unnecessary additional distress or trauma to the patient. Attachment of conduits to the grommet member may be by the supplier and/or manufacturer of the grommet or may be threaded into the aperture by a care giver or clinician.
In the case of the dressing backing layer having a bite out of one edge, the protector and support layers may be easily removed from around the conduit or conduits. However, in the case of the backing layer having a closed aperture, it is necessary for the support layer to be cut in some manner in order to clear the conduit(s) when being removed. In this regard the support layer could be torn or cut with a pair of scissors, for example, but preferably all three layers are cut through one side during manufacture of the dressing.
The grommet member is provided with at least one aperture therethrough to receive a conduit or conduits. Where a plurality of conduits are required as in the treatment of wounds involving TNP therapy together with irrigation and/or cleansing as described in our co-pending International patent applications referred to hereinabove, separate apertures may be provided for each conduit or tube having a single lumen therethrough, for example. Alternatively, a single conduit having a plurality of lumens therethrough may be employed and the aperture through the grommet member may be suitably shaped, for example, as an elongate “flat” hole in cross section.
It is preferred that the at least one aperture through the grommet member is provided with sealing means to seal the conduit(s) which pass therethrough against leakage of fluid in use. Such sealing means preferably comprise flexible lip seals, “O” ring-type seals or sleeve-shaped seals which co-operate with the outer surface of the conduit(s). The provision of such lip seals render the conduit to grommet aperture interface leak-free and also reduces the force necessary to adjust the position of the conduit(s) in the grommet member when adhered to the patient with obvious benefit thereto.
In some embodiments, the grommet member and seal may be formed from relatively rigid material. Seals when made in a rigid form generally work as well as soft materials as the conduits employed are generally made from relatively soft and conformable material.
The dressing backing layer member and the grommet member may initially be supplied as two separate integers of the dressing of the present invention having the various protector and support layers as appropriate and the two integers then being assembled when being applied to the patient. However, it is preferred that the grommet member is attached to the backing layer at a manufacturing step in a manufacturing process.
Where the grommet member is supplied already adhered to the surrounding backing layer, the protector layer may be provided as a single piece covering the adhesive coated faces of both the backing layer and the grommet member, whether or not the latter is adhesively coated.
It is further preferred that the dressing may be supplied having the backing layer and grommet member joined and also having the appropriate conduit(s) already installed in the at least one aperture of the grommet member.
Where the backing layer and grommet member are supplied as two separate integers, the protector layer on the backing layer maybe provided in a plurality of portions, cut through and/or provided during a manufacturing process. For example, the protector layer adjacent the cut out portion may be in the form of a separately removable narrow border corresponding substantially to the width of the grommet member flange portion, this border portion being removed first to enable the grommet member to be initially adhered to the backing layer.
In known manner the protector layer may be formed of a plurality of portions to enable improved ease of handling and manipulation of the dressing when applying same to the patient. In this regard the protector layer may be arranged such that most of it is removed initially, so that the dressing may be conveniently and accurately positioned on the patient, whilst leaving a smaller, folded back portion of protector to be finally removed for the remainder of the adhesive coated backing layer to be adhered to the patient without the possibility of the adhesive layer being contaminated by the fingers of the clinician, for example, applying the dressing. After adhering the dressing to the patient, the support layer may be finally peeled away leaving the backing layer, grommet member with conduits in place. A final flexible drape covering of a known adhesive coated material such as OPSITE (trade mark), for example, may then be put in place substantially covering the adhered backing layer, the grommet member, the conduits situated within the wound site environment and the remainder of the wound area.
In a third embodiment of the dressing of the present invention, the backing layer may comprise two separate portions with the adhesive coated faces facing each other and the grommet member sandwiched between the two adhesive coated faces. In this embodiment a first portion of backing layer is effectively folded in two with protector layers on the outwardly facing adhesive coated faces. The protector layer from one of the two faces of the first portion is first removed and the exposed adhesive coated face is stuck to the patient's skin in a suitable position relative to the wound. The second piece of protector layer is then removed from the upwardly facing adhesive coated face and the grommet member then adhered to this second surface of the first portion. A second portion of backing material may then be placed to overlie the grommet member to sandwich it between the first and second backing layer portions. It is preferred that the length of the two backing layer portions is in the range from 1× to 5× the lateral width of the grommet member so that the excess length of each backing layer portion is sufficient to form a strong bond with each other either side of the grommet. The second portion may, if desired, also be folded in two so that the grommet member is sandwiched between the adhesive coated face of the first and second backing layer portions and the remaining upwardly facing face of the second portion is also adhesive coated. Thus, with the grommet member in place on the patient's skin, the second backing layer portion may be left with a piece of protector material on the upwardly facing adhesive coated face, which protector material may be finally peeled away immediately prior to the whole of the dressing and remaining wound area being covered with a flexible drape covering as in the preceding embodiments.
However, whilst the dressing referred to above has the first and second backing layer pieces in the length range 1× to 5×, they may, in fact, be much longer where, for example, the folded piece or pieces are laid across the diameter or width of a large wound.
However, it is not necessary in the third embodiment for the second portion of backing layer to be folded in two. The second portion of backing layer may be a single layer having the adhesive coated face protected with a protector layer and the reverse, non-adhesive coated face protected with a support layer as in the preceding embodiments. In this case the grommet member will be sandwiched between the adhesive coated faces of the first and second backing layers leaving the upwardly facing, non-adhesive coated face of the second backing layer portion protected by a support layer. The support layer may then be peeled away immediately prior to the dressing and the remainder of the wound site being covered with a flexible, adhesive coated film material which adheres to the upwardly facing face of the second backing layer portion to seal the grommet member against ingress of ambient air.
Examples of suitable materials for the backing layer for the dressings according to the present invention and also the overlying flexible drape film may be that known as OPSITE (trade mark) or TEGADERM (trade mark).
In the third embodiment of the dressing of the present invention the first and second backing layer portions may be supplied or provided as flat pieces of suitable material comprising backing layer, protector layer and support layer, the clinician then preparing same by peeling away protector layers, folding and adhering to the patient as necessary with the step of including the grommet member between the first and second backing layers. However, the dressing of the third embodiment may be provided in an assembled form with the grommet member being sandwiched between the two separate first and second portions of backing material with the outwardly facing faces having the appropriate protective protector layers or protector and support layers remaining in place for removal prior to adhering to a patient.
In the third embodiment, the second, upper backing layer portion may, in fact, be the overlying drape which covers the entire wound site.
In the third embodiment of a dressing according to the present invention, the grommet member may have a generally elliptical shape when viewed end on in a direction parallel to the axis of the at least one aperture therethrough.
The lateral ends of the grommet member used in the third embodiment may have the two outer surfaces thereof tapering into a fine edge with each other at each lateral end thereof so as to facilitate the joining of the first and second backing layer portions where they meet at each lateral end of the grommet member.
In the present invention the dressing is effectively sealed to the skin surrounding the wound by the overlying adhesively coated flexible drape film. However, the term “sealed” is not an absolute requirement or practically attainable since many flexible dressing membrane materials forming the wound cover are composed of semi-permeable plastics materials which are well known to those skilled in the art. Furthermore, there is almost inevitably some leakage between the skin and the sealing dressing material which is adhered thereto, usually by well known pressure sensitive adhesives, due to hairs and/or other skin surface irregularities and/or imperfections which are not easily completely sealed in absolute terms. The types of self adhesive, flexible dressing drape materials which are ordinarily used in TNP type therapy for sealing membranes over and around wounds are well know to those skilled in the art and will not be elaborated on further herein unless necessary.
Similarly as to the above with regard to the adhesive layer or coating on the flexible drape sealing film, there are very many suitable adhesives which may be used alternatively to pressure sensitive adhesives and include acrylic, silicone, stoma adhesives, hot melt adhesives and solvent spread adhesives, for example. The person skilled in the art will accordingly choose the most appropriate adhesive to the circumstances.
In order that the present invention may be more fully understood, examples by way of illustration only will now be described with reference to the accompanying drawings, of which:
Referring now to the drawings and where the same or similar features are denoted by common reference numerals.
The grommet member of
In use (where the grommet member 10 is not already adhered to the dressing component 30) the narrow protector layer 40 is peeled away from the adhesive coated face 46 to expose the border portion 52 of adhesive. The grommet member 10 is then entered into the cut out portion 48 such that the upper surface of the flange portion 16 of the grommet is adhered to the border 52 on three sides (note that at this stage the required conduits have already been inserted into the aperture 14). The dressing assembly 10, 30 is then adhered to a patient in a suitable position adjacent a wound (not shown) which is achieved by peeling away the protector layer main portion 36 (and any protector layer that the grommet member may have on its lower surface if it has an adhesive coating). The combined dressing components 10, 30 are then positioned over the desired position on the patient and pressed down in place, the rear end of the dressing at area 50 then being lifted slightly to enable the second, folded portion 38 of the protector layer to be removed and area 50 of the backing layer 32 then pressed down onto the patient's skin. Finally, the upper support layer 42 may then be peeled away to leave the dressing in place. Normally, a further flexible self-adhesive drape covering (not shown but see
The provision and methods of manufacture of the various layers and constituent portions described above and in succeeding embodiments will be well known to those skilled in the art. The small protective layer 40 may be separated from the main portion by a “kiss cut”, for example, on a strip of material having a plurality of such dressing components passing through a manufacturing machine.
A dressing component 90 of a second embodiment of the present invention is shown in
The backing layer 92 does not need to have the slit 110 therein as this layer remains on the patient. The slit 110 may, however, facilitate manufacture of the dressing 90.
The dressing component 90 of the second embodiment may be used with either of the grommet members 10, 70 described hereinabove. In use, in essentially the same way as with the dressing component 30 of
The second embodiment of the dressing according to the present invention is considered to have the advantage that the grommet member is held down to the patient's skin along all four edges of the flange portion thus further reducing the possibility of any leakage either inwardly or outwardly of the dressing.
The second embodiment also substantially removes the need for the grommet member to have an adhesive coating on its lower face.
The above embodiments comprising grommet members 10 or 70 and dressing components 30 or 90 as desired may be put into effect at a manufacturing stage whereby the grommet member 10 or 70 is pre-adhered to the dressing component 30 or 90 during manufacture. In this way the protective layer may be made into a single piece which extends over substantially the whole of the adhesive coated area including the lower face of the grommet member which may or may not be adhesive coated. The pre-assembled dressing may also be provided with suitable conduits and the whole assembly packaged in a sealed bag and sterilised by known techniques.
Optionally the backing layer portions 144 and 142 may have a support layer (not shown) which can be removed at the end of the application of the backing layer 144.
The kiss cut 156 is optional since it is possible to remove the protector material layers 152, 158 as one but handling is less easy without the cut 156.
A modified example of the third embodiment is shown in
An advantage of using the backing layer 144 as shown in
The third embodiments of
Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of the words, for example “comprising” and “comprises”, means “including but not limited to”, and is not intended to (and does not) exclude other moieties, additives, components, integers or steps.
Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith.
Number | Date | Country | Kind |
---|---|---|---|
0712735.0 | Jul 2007 | GB | national |
The present application claims priority to U.S. Provisional Application 60/833,553 filed Jul. 26, 2006 and Great Britain Application GB0712735.0 filed Jul. 2, 2007, both of which are hereby incorporated by reference in their entireties.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2007/074374 | 7/25/2007 | WO | 00 | 1/6/2010 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2008/014358 | 1/31/2008 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3682180 | McFarlane | Aug 1972 | A |
3713622 | Dinger | Jan 1973 | A |
3826254 | Mellor | Jul 1974 | A |
4261363 | Russo | Apr 1981 | A |
4333468 | Geist | Jun 1982 | A |
4382441 | Svedman | May 1983 | A |
4392853 | Muto | Jul 1983 | A |
4525166 | Leclerc | Jun 1985 | A |
4543100 | Brodsky | Sep 1985 | A |
4743232 | Kruger | May 1988 | A |
4906233 | Moriuchi et al. | Mar 1990 | A |
4941882 | Ward et al. | Jul 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
5100396 | Zamierowski | Mar 1992 | A |
5160315 | Heinecke et al. | Nov 1992 | A |
5261893 | Zamierowski | Nov 1993 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5618556 | Johns et al. | Apr 1997 | A |
5636643 | Argenta | Jun 1997 | A |
5645081 | Argenta | Jul 1997 | A |
6117111 | Fleischmann | Sep 2000 | A |
6142982 | Hunt et al. | Nov 2000 | A |
6345623 | Heaton et al. | Feb 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6471685 | Johnson | Oct 2002 | B1 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7117869 | Heaton et al. | Oct 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7216651 | Argenta et al. | May 2007 | B2 |
7316672 | Hunt et al. | Jan 2008 | B1 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7485112 | Karpowicz et al. | Feb 2009 | B2 |
7534927 | Lockwood et al. | May 2009 | B2 |
7611500 | Lina et al. | Nov 2009 | B1 |
7651484 | Heaton et al. | Jan 2010 | B2 |
7670323 | Hunt et al. | Mar 2010 | B2 |
7678102 | Heaton | Mar 2010 | B1 |
7726560 | Mittal et al. | Jun 2010 | B2 |
7776028 | Miller et al. | Aug 2010 | B2 |
7909805 | Weston | Mar 2011 | B2 |
20020115952 | Tumey | Aug 2002 | A1 |
20020161346 | Lockwood et al. | Oct 2002 | A1 |
20030040687 | Boynton et al. | Feb 2003 | A1 |
20040030304 | Hunt et al. | Feb 2004 | A1 |
20040073151 | Weston | Apr 2004 | A1 |
20040243073 | Lockwood | Dec 2004 | A1 |
20050203452 | Weston et al. | Sep 2005 | A1 |
20050222527 | Miller et al. | Oct 2005 | A1 |
20050222528 | Weston | Oct 2005 | A1 |
20050222544 | Weston | Oct 2005 | A1 |
20050261615 | Weston | Nov 2005 | A1 |
20050261642 | Weston | Nov 2005 | A1 |
20070239139 | Weston et al. | Oct 2007 | A1 |
20080243044 | Hunt et al. | Oct 2008 | A1 |
20090054855 | Blott et al. | Feb 2009 | A1 |
20090177172 | Wilkes | Jul 2009 | A1 |
20090312727 | Heaton | Dec 2009 | A1 |
20100036367 | Krohn | Feb 2010 | A1 |
Number | Date | Country |
---|---|---|
1320888 | Aug 1993 | CA |
2198243 | Feb 1996 | CA |
2551340 | May 1997 | CA |
2471780 | Mar 1999 | CA |
0 284 219 | Sep 1988 | EP |
1 088 569 | Apr 2001 | EP |
2 227 203 | Sep 2010 | EP |
2 329 127 | Mar 1999 | GB |
2 356 148 | May 2001 | GB |
H08-024344 | Jan 1996 | JP |
2002-035133 | Feb 2002 | JP |
2002-507435 | Mar 2002 | JP |
WO 8802248 | Apr 1988 | WO |
WO 9100718 | Jan 1991 | WO |
WO 9605873 | Feb 1996 | WO |
WO 9733643 | Sep 1997 | WO |
WO 9913793 | Mar 1999 | WO |
WO 0134223 | May 2001 | WO |
WO 03057071 | Jul 2003 | WO |
WO 2005105180 | Nov 2005 | WO |
WO 2008041926 | Apr 2008 | WO |
WO 2009088757 | Jul 2009 | WO |
WO 2009088925 | Jul 2009 | WO |
WO 2009088925 | Sep 2009 | WO |
Entry |
---|
US 6,216,701, 04/2001, Heaton et al. (withdrawn) |
U.S. Appl. No. 10/652,200, filed Aug. 28, 2003, Richard S. Weston. |
U.S. Appl. No. 11/075,020, filed Mar. 8, 2005, Richard S. Weston, et al. |
U.S. Appl. No. 11/095,859, filed Mar. 31, 2005, Miller et al. |
U.S. Appl. No. 11/098,203, filed Apr. 4, 2005, Richard S. Weston. |
U.S. Appl. No. 11/098,265, filed Apr. 4, 2005, Richard S. Weston. |
U.S. Appl. No. 11/132,549, filed May 19, 2005, Richard S. Weston. |
U.S. Appl. No. 11/064,813, filed Feb. 24, 2005, Weston, Richard S. |
U.S. Appl. No. 11/874,021, filed Apr. 5, 2007, Weston et al. |
Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” Current Problems in Modern Clinical Surgery, 1986, 4 pages. |
Boretos, John W., Cellular Polymers for Medical Use: The Vital Role of Porosity and Permeability, Cellular Polymers, 1984, vol. 3, pp. 345-358. |
Chariker, M.E., et al, “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage,” Contemporary Surgery. Jun. 1989, pp. 59-63, vol. 34 USA. |
Eaglstein, W.H., et al., Wound Dressings: Current and Future, Clin. and Exper. Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds, 1991, 257-265. |
Eisenbud, D.E., Modern Wound Management, Anadem Publishing, Chap. 16, 109-116, 1999. |
International Search Report, International Application No. PCT/US07/074374, dated Mar. 27, 2008, in 6 pages. |
International Preliminary Report, International Application No. PCT/US07/074374, dated Jan. 27, 2009, in 11 pages. |
Jeter, Katherine F. ET, Managing Draining Wounds and Fistulae: New and Established Methods, Chronic Wound Care, Chapter 27, pp. 240-246, 1990. |
Schein et al., “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery, 1986, vol. 73, May, pp. 369-370. |
U.S. Appl. No. 12/186,424, filed Aug. 5, 2008, Krohn. |
Written Opinion dated Jan. 26, 2009 in application No. PCT/US07/74374 in 10 pages. |
Number | Date | Country | |
---|---|---|---|
20100106114 A1 | Apr 2010 | US |
Number | Date | Country | |
---|---|---|---|
60833553 | Jul 2006 | US |